TNF and coronary artery disorder: Furthermore, testosterone replacement therapy can reduce circulating levels of inflammatory mediators including tumor necrosis factor α (TNF-α) and interleukin (IL)-1β, as well as total cholesterol in patients with established simultaneous coronary artery disease and testosterone deficiency [9, 10].